HPS Pharmacies wish to advise that Gilead Sciences Pty Ltd have given notice of an
urgent drug recall of:
Ambisome® powder for injection vial
|Contents||amphotericin B, 50mg|
This recall is because it has been identified that there is a risk that this batch may have been contaminated with Sphingomonas yanoikuyae during manufacture.
The recall is a precautionary measure as contamination has not been demonstrated, and adverse reactions have not been reported for this batch. Sphingomonas yanoikuyae has not been reported to cause disease in humans.
Please inspect your stocks and quarantine all units from the above batch number for return to your supplier who will arrange for refund or replacement. Any items from these batches supplied by HPS Pharmacies should be returned to the pharmacy for processing.
There is not expected to be any interruption of supply as alternative batches are available.
This recall notice does not affect any other batches of Ambisome® or medicines supplied by Gilead Sciences.
Please retain this notice in a prominent position, including other related business units for one month in case stock is in transit. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please do not hesitate to contact your pharmacist at HPS Pharmacies or Gilead Sciences Pty Ltd on 1800 806 112.
Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.